¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"treatment cost effectiveness"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cost-effectiveness analysis
    ºñ¿ëÈ¿°úºÐ¼®
  • effectiveness
    1. À¯È¿µµ 2. È¿À² 3. À¯¿ëµµ
  • relative biologic effectiveness radiation
    »ó´ë»ý¹°ÇÐÀûÈ¿°ú¹æ»ç¼±
  • cost-benefit analysis
    ºñ¿ëÆíÀͺм®
  • cost-efficiency analysis
    ºñ¿ëÈ¿À²ºÐ¼®
  • cost-utility analysis
    ºñ¿ëÈ¿¿ëºÐ¼®
  • medical cost
    ÀÇ·áºñ
  • active treatment
    Àû±ØÄ¡·á
  • conservative treatment
    º¸Á¸Ä¡·á
  • drug treatment
    ¾à¹°Ä¡·á
  • eventration treatment
    Àå±â³ëÃâÄ¡·á
  • expectant treatment
    ±â´ëÄ¡·á
  • local treatment
    ±¹¼ÒÄ¡·á
  • mass treatment
    Áý´ÜÄ¡·á
  • orthodontic treatment
    ±³Á¤Ã³Ä¡
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effectiveness
    È¿°ú, À¯È¿
  • self-treatment
    ÀÚ°¡Ä¡·á
  • treatment
    Ä¡·á, óġ
  • conservative treatment
    º¸Á¸Ä¡·á
  • dietetic treatment
    À½½ÄÄ¡·á
  • drug treatment
    ¾à¹°Ä¡·á
  • local treatment
    ±¹¼ÒÄ¡·á
  • mass treatment
    Áý´ÜÄ¡·á
  • occlusive treatment
    °¡¸²Ä¡·á
  • palliative treatment
    ¿ÏÈ­Ä¡·á, °í½ÄÄ¡·á
  • preventive treatment
    ¿¹¹æÄ¡·á
  • psychoanalytic treatment
    Á¤½ÅºÐ¼®Ä¡·á
  • radical treatment
    ±Ùġġ·á, ±Ùº»Ä¡·á
  • salvage treatment
    ±¸Á¦Ä¡·á
  • shock treatment
    Ãæ°ÝÄ¡·á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cost-effectiveness analysis
    ºñ¿ëÈ¿°úºÐ¼®
  • effectiveness
    È¿°ú, À¯È¿
  • relative biologic biologic effectiveness radiation
    »ó´ë»ý¹°ÇÐÀûÈ¿°ú
  • cost awareness
    ºñ¿ëÀÚ°¢
  • cost-benefit analysis
    ºñ¿ëÆíÀͺм®
  • cost-efficiency analysis
    ºñ¿ëÈ¿À²ºÐ¼®
  • cost-utility analysis
    ºñ¿ëÈ¿¿ëºÐ¼®
  • cost
    ºñ¿ë
  • medical cost
    ÀÇ·áºñ
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • active treatment
    Àû±ØÄ¡·á
  • aseptic treatment
    ¹«±ÕÄ¡·á
  • autoserum treatment
    ÀÚ°¡Ç÷ûġ·á
  • blanket mass treatment
    Àü¿øÄ¡·á
  • combination treatment
    º´¿ëÄ¡·á
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cost-effectiveness
    ºñ¿ëÈ¿À²¼º
  • Cost awareness
    ºñ¿ëÀÚ°¢
  • hospital cost
    ÀÔ¿ø ºñ¿ë,º´¿øºñ
  • radiation,relative biologic effectiveness(rbe)
    »ó´ëÀû(ºñ±³Àû)»ý¹°ÇÐÀûÈ¿°ú(ßÓÓßîÜ(ÝïÎòîÜßæÚªùÊîÜüùÍý)
  • relative biologic effectiveness of radiation
    ¹æ»ç¼±ÀÇ»ó´ëÀû»ý¹°ÇÐÀûÈ¿°ú(Û¯ÞÒàÊ¡­ßÓÓßîÜßæÚªùÊîÜüùÍý)
  • relative biological effectiveness
    »ó´ëÀû »ý¹°ÇÐÀû È¿°ú(ßÓÓßîÜßæÚªùÊîÜüù
  • relative biological effectiveness
    »ó´ë»ý¹°ÇÐÀûÈ¿°ú
  • Calots treatment
    Ä®·Î¿ä¹ý.
  • Carrels treatment
    Ä«·¼¿ä¹ý.
  • Castellanis treatment
    Ä«½ºÅÚ¶ó´Ï¿ä¹ý.
  • Co-Tuis treatment
    ÄÚÅõÀÌ¿ä¹ý.
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • acoustic treatment
    ÈíÀ½Ã³¸®
  • active treatment
    Á÷Á¢Ä¡·á, Àû±Ø¿ä¹ý(îÝпèþÛö).
  • antifat treatment
    Å»Áö¿ä¹ý(÷­ò·èþÛö).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • treatment cost effectiveness
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cost-effectiveness analysis
    ºñ¿ë-È¿°úºÐ¼®.
  • cost-benifit analysis
    ºñ¿ë-ÆíÀͺм®.
  • cost-efficiency analysis
    ºñ¿ë-È¿À²ºÐ¼®.
  • hospital cost
    ÀÔ¿ø ºñ¿ë,º´¿øºñ
  • low cost food plan
    ¿°°¡½Ä»ç°èȹ.
  • medical cost
    ÀÇ·áºñ.
  • biological effectiveness
    [°áÇÙ,ÀÓº´,¹ÙÀÌ] »ý¹°ÇÐÀû È¿°ú (¡­üùÍý).
  • biological effectiveness
    ¾à ¸® ¹Ì»ý,±â»ý,³»°ú,°áÇÙ,ÀÓº´ ºñÀÌ »ý¹°ÇÐÀû È¿°ú (¡­üùÍý).
  • effectiveness
    È¿°ú.
  • radiation,relative biologic effectiveness(rbe)
    »ó´ëÀû(ºñ±³Àû)»ý¹°ÇÐÀûÈ¿°ú(ßÓÓßîÜ(ÝïÎòîÜßæÚªùÊîÜüùÍý)
  • relative biologic effectiveness of radiation
    ¹æ»ç¼±ÀÇ»ó´ëÀû»ý¹°ÇÐÀûÈ¿°ú(Û¯ÞÒàÊ¡­ßÓÓßîÜßæÚªùÊîÜüùÍý)
  • relative biological effectiveness
    »ó´ë»ý¹°ÇÐÀûÈ¿°ú
  • relative biological effectiveness
    »ó´ëÀû »ý¹°ÇÐÀû È¿°ú(ßÓÓßîÜßæÚªùÊîÜüù
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • acoustic treatment
    ÈíÀ½Ã³¸®
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blanket mass treatment
    Àü¿øÁý´ÜÄ¡·á¹ý
  • mass treatment
    Áý´ÜÄ¡·á
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Briggs-Haldane treatment
    ºê¸¯½º-ÇÒµ§ ó¸®(ô¥×â)
  • Michaelis-Menten treatment
    ¹ÌŰ¿¤¸®½º-¸àÅ٠ó¸®(ô¥×â)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cost-effectiveness
    ºñ¿ëÈ¿À²
  • local treatment
    ±¹¼ÒÄ¡·á, ±¹¼Ò¿ä¹ý
  • palliative treatment
    °í½ÄÀûÄ¡·á
  • radical treatment
    ±ÙÄ¡¿ä¹ý
  • supportive treatment
    ÁöÁö¿ä¹ý
  • surgical treatment
    ¿Ü°ú¿ä¹ý
  • treatment
    Ä¡·á, ¿ä¹ý, ó¸®, óġ
  • treatment of choice
    ÃÖÀû¿ä¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CEA carcinoembryonic antigen; carotid endarterectomy; cholesterol-esterifying activity; cost-effectivene...
ECR effectiveness-cost ratio; electrocardiographic response; emergency care research; emergency chemical...
AAPCC adjusted annual per capita cost; adjusted average per capita cost; American Association of Poison Co...
ACT achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ...
HT Hashimoto thyroiditis; hearing test; hearing threshold; heart; heart transplantation, heart transpla...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CEA Cost Effectiveness Analysis
CE Cost-effectiveness
CEAs Cost-effectiveness analyses
CER Cost-effectiveness ratio
ICER incremental cost effectiveness ratio
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cost-effectiveness
    ºñ¿ë È¿À²
  • cost
    Ä¡·áºñ
  • relative biological effectiveness
    »ó´ëÀû »ý¹°ÇÐÀû È¿°ú
  • abortive treatment
    ºÎÀü ¿ä¹ý
    °¨¿° Á÷ÈÄ
  • age treatment
    ½ÃÈ¿ ó¸®
    ½ÃÈ¿ °æÈ­¸¦ ´Ü½Ã°£¿¡ ÀÏÀ¸Å°±â À§ÇØ °¡¿­ÇÏ´Â ¿­ ó¸®.
  • Bargen's treatment
    ¹Ù¸£°Õ
    Ç÷û¿¡ ÀÇÇÑ ´ëÀå¿°ÀÇ ¿ä¹ý.
  • biological treatment
    »ý¹°ÇÐÀû ó¸®
  • combination treatment
    º´¿ë¹ý
  • combined waste water treatment
    °øµ¿ Æó¼ö ó¸®
  • complex treatment issue
    º¹ÇÕ Ä¡·á ¹®Á¦
  • conservative treatment
    º¸Á¸Àû Ä¡·á
  • dental treatment
    Ä¡°ú Ä¡·á
    ±¸°­ ¾Ç¾È¸é ¿µ¿ªÀÇ ÀÌ»óÀ» °Þ°í Àִ ȯÀÚ¸¦ Ä¡·áÇÏ´Â °Í.
  • drug treatment
    ¾à¹° ¿ä¹ý
  • early treatment
    Á¶±â Ä¡·á
    Ä¡·á È¿°ú¸¦ ¿Ã¸®±â ½¬¿î ½Ã±â¿¡ Ä¡·á¸¦ ÇàÇÏ´Â °Í.
  • external analgesic treatment
    ¿ÜÀμº ÁøÅë ¿ä¹ý, ¿ÜÀμº ÁøÅë Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
relative biological effectiveness The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.
(12 Dec 1998)
effectiveness 1. A measure of the accuracy or success of a diagnostic or therapeutic technique when carried out in an average clinical environment.; Cf.
See: efficacy.
2. The extent to which a treatment achieves its intended purpose.
(05 Mar 2000)
capital cost The total investment needed to complete a project and bring it to a commercially operable status. The cost of construction of a new plant. The expenditures for the purchase or acquisition of existing facilities.
(05 Dec 1998)
cost allocation The assignment, to each of several particular cost-centres, of an equitable proportion of the costs of activities that serve all of them. Cost-centre usually refers to institutional departments or services.
(12 Dec 1998)
cost-benefit analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
(12 Dec 1998)
cost control The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured.
(12 Dec 1998)
cost-effective A term describing a resource that is available within the time it is needed and is able to meet or reduce electrical power demand at an estimated incremental system cost no greater than that of the least-costly, similarly reliable and available alternative.
(05 Dec 1998)
cost of illness The personal cost of acute or chronic disease. The cost to the patient may be an economic, social, or psychological cost or loss to himself, his family, or community. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, quality of life, etc. It differs from health care costs in that this concept is restricted to the cost of providing services related to the delivery of health care rather than an impact on the personal life of the patient.
(12 Dec 1998)
costs and cost analysis Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs.
(12 Dec 1998)
cost savings Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer.
(12 Dec 1998)
cost sharing Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage.
(12 Dec 1998)
sunk cost A cost already incurred and therefore not considered in making a current investment decision.
(05 Dec 1998)
overnight capital cost The capital cost of a project if it could be constructed overnight. This cost does not include the interest cost of funds used during construction.
(05 Dec 1998)
technology, high-cost Advanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialised medical/surgical procedures as well as advanced diagnostic and therapeutic equipment.
(12 Dec 1998)
least cost planning (integrated resource planning) A method of power planning that recognises load uncertainty, embodies an emphasis on risk management, and reviews all available and reliable resources to meet future loads. It takes into consideration all costs of a resource, including capital, labour, fuel, maintenance, decommissioning, known environmental impacts, and the difficulty in quantifying the consequences of selecting one resource over another. Least cost planning seeks to minimise total energy costs.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cost effectiveness (ecciciency)
    ºñ¿ëÈ¿°ú 9
  • effectiveness
    À¯È¿(¼º);È¿°úÀûÀÓ
  • relative biological effectiveness
    »ý¹°ÇÐÀû È¿°úºñ;»ý¹°È¿°úºñ
  • treatment
    Ãë±Þ
  • Pasteur treatment
    ±¤°ßº´ ¿¹¹æ Á¢Á¾
  • heat treatment
    ¿­Ã³¸®
  • medical treatment
    (³»°úÀû)Ä¡·á
  • national treatment
    (¿Ü±³)³»±¹¹Î ´ë¿ì
  • pneumothorax treatment
    ±âÈä¼ú
  • preferential treatment
    ¿ì´ë
  • treatment
    ó¸®;°¡°ø;´ë¿ì;´ëÁ¢;(ÀÇ»çÀÇ)Ä¡·á(¹ý);Ä¡·áÁ¦
  • cost
    ¿äÇÏ´Ù,ºñ¿ë,°ª
  • cost
    (Á¦ÀÛ.°ø»çµîÀÇ)¿ø°¡;ºñ¿ë;°æºñ;(»óǰ.¼­ºñ½º¿¡´ëÇÑ)´ë°¡;°ª;°¡°Ý;(Àθí.½Ã°£.³ë·ÂµîÀÇ)Èñ»ý;¼Õ½Ç;°íÅë;¼Ò¼Ûºñ¿ë;(ºñ¿ë.´ë°¡°¡ ¾ó¸¶)µé´Ù;(...¿¡°Ô ¾ó¸¶¸¦)µé°Ô(Ä¡¸£°Ô)ÇÏ´Ù;(½Ã°£.³ë·ÂµîÀ»)¿äÇÏ´Ù;(±ÍÁßÇÑ °ÍÀ»)Èñ»ýÇϰÔÇÏ´Ù;ÀÒ°ÔÇÏ´Ù;(¾î¶² °íÅëÀ»)ÁÖ´Ù;ºñ¿ëÀÌ µé´Ù;¿ø°¡¸¦
  • cost accountant
    ¿ø°¡ °è»ê ´ã´çÀÚ
  • cost accounting
    ¿ø°¡ °è»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á